|
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Venous Thromboembolism
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.
|
31420334 |
2019 |
|
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus.
|
11511096 |
2001 |
|
Serum total cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
|
Serum HDL cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
|
Serum HDL cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
|
Schizophrenia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increased exonic de novo mutation rate in individuals with schizophrenia.
|
21743468 |
2011 |
|
Pulmonary arterial hypertension
|
0.010 |
Biomarker
|
disease |
BEFREE |
A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H<sub>2</sub>O and -SNO intermolecular stabilization chemistry.
|
30227269 |
2018 |
|
Pneumococcal Infections
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Genetic ablation of the clock gene Bmal1 (also called Arntl or MOP3) in bronchiolar cells disrupts rhythmic Cxcl5 expression, resulting in exaggerated inflammatory responses to lipopolysaccharide and an impaired host response to Streptococcus pneumoniae infection.
|
25064128 |
2014 |
|
Parkinson Disease 6, Autosomal Recessive Early-Onset
|
0.010 |
Biomarker
|
disease |
BEFREE |
SNO-PINK1 decreases Parkin translocation to mitochondrial membranes, disrupting mitophagy in cell lines and human-iPSC-derived neurons.
|
29166608 |
2017 |
|
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE
|
0.010 |
Biomarker
|
disease |
BEFREE |
SNO-PINK1 decreases Parkin translocation to mitochondrial membranes, disrupting mitophagy in cell lines and human-iPSC-derived neurons.
|
29166608 |
2017 |
|
Parkinson Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
Moreover, we detect SNO-PTEN in human brains with sporadic PD.
|
25378175 |
2014 |
|
Parkinson Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
We observed increased SNO-Prx2 in human Parkinson's disease (PD) brains, and S-nitrosylation of Prx2 inhibited both its enzymatic activity and protective function from oxidative stress.
|
18003920 |
2007 |
|
Parkinson Disease
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We first showed that SNO-Parkin reduced its ability as a suppressor of Drp1 expression, leading to upregulation of Drp1 in neurotoxin-based PD models, in vitro and in vivo.
|
27267045 |
2016 |
|
Osteoarthritis, Knee
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data.
|
30664745 |
2019 |
|
Osteoarthritis, Knee
|
0.400 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis.
|
30374069 |
2018 |
|
Osteoarthritis, Knee
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis.
|
30374069 |
2018 |
|
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Copy numbers of EVI1 and TERC increased more than those of SNO and PIK3CA in our panel of NSCLC cell lines.
|
14581340 |
2003 |
|
Neurodegenerative Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
'SNO'-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders.
|
29097102 |
2017 |
|
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we found that S-nitrosylation of O-linked N-acetylglucosaminyltransferase (SNO-OGT) was induced by β-amyloid peptide (Aβ) exposure to SK-N-MC and SK-N-SH human neuroblastoma cells.
|
26854602 |
2016 |
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
To discuss the role of survivorship care and survivorship care plans, including a recently developed neuro-oncology-specific plan care (https://www.soc-neuro-onc.org/SNO/Resources/Survivorship_Care_Plan.aspx) for adult patients diagnosed with primary glial neoplasms and the necessary educational needs of oncology nurses.
|
30446382 |
2018 |
|
Multiple Chronic Conditions
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study confirmed that the TPZ/HMTNPs-SNO with multi-mechanisms exploited the merits of synergistic combination of the three therapeutic modes, consequently potentiating the anticancer efficacy of SDT.
|
29474964 |
2018 |
|
Malignant neoplasm of esophagus
|
0.030 |
Biomarker
|
disease |
BEFREE |
We investigated the antiproliferative effects of AuNP synthesized from MO aqueous leaf extracts (MLAuNP ) in A549 lung and SNO oesophageal cancer cells.
|
26923760 |
2016 |
|
Malignant neoplasm of esophagus
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
This study investigated FA-induced cytotoxicity and apoptotic induction in the SNO OC cell line.
|
27956242 |
2017 |
|
Malignant neoplasm of esophagus
|
0.030 |
Biomarker
|
disease |
BEFREE |
A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells.
|
28530542 |
2018 |